ATHLONE, Ireland (AP) _ Innocoll AG (INNL) on Thursday reported a loss of $3.8 million in its fourth quarter.
On a per-share basis, the Athlone, Ireland-based company said it had a loss of 13 cents. Losses, adjusted for non-recurring gains, were 26 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.
The specialty pharmaceutical company posted revenue of $590,000 in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $716,000.
For the year, the company reported a loss of $57 million, or $2.12 per share. Revenue was reported as $4.4 million.
In the final minutes of trading on Thursday, the company's shares hit $1.88. A year ago, they were trading at $8.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INNL at https://www.zacks.com/ap/INNL
Keywords: Innocoll, Earnings Report